WebinarJanuary2018 2018-01-18T22:01:25+00:00
Menu

Home     Search     Webinars                                                                                                                     TMIT FAQs    About Us     Disclosures     Login

January 18, 2018, 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET

Drug Diversion: A Drill Down Approach  

Session Overview

The webinar for this month is a follow up and detailed approach to the exploding drug diversion problem following an excellent and informative program September 21 of 2017 by Kimberly New. She will drill down on tactical detail regarding how an organization needs to deal with this issue.

Kimberly New is a specialist in controlled substance security and DEA regulatory compliance and consults with healthcare facilities across the country. She is an attorney and an RN who will provide practical and powerful insights to the exploding drug diversion problem.  She is widely published and advises a number of leading medical centers.

A reactor panel of patient advocates and subject specific experts will react to the presentation.

We offer these online webinars at no cost to our participants.

……………………………………………………………………………………………………..

Webinar Video, and Downloads

Click here to download the National Survey Results.   

Speaker Slide Set:

Click here to download the combined speakers’ slide set in PDF format – one (1) slide per page.  

To view the file, click the desired link (please note: the files may take several minutes to download). To save to your hard drive, right click on the link and choose “Save Target As.” (In some browsers it might say “Save Link As.”)

……………………………………………………………………………………………………..

Registration Information and CE Credit Information

 Register:
This webinar has previously aired.

  When:  January 18, 2018   Time: 12:00 pm – 1:30 pm CT / 1:00 pm – 2:30 pm ET
We are accepting questions now that relate to the session topics. Please e-mail any questions related to the specific session to webinars@safetyleaders.org with the session title in the e-mail message header.

  • Questions about the Webinar series?
    E-mail webinars@safetyleaders.org or call 512-473-2370 between 9:00 a.m. and 4:30 p.m. CT.
  • Need technical assistance with registration? Call 512-457-7605 between 9:00 a.m. and 4:30 p.m. CT.

Learning Objectives:

  • Awareness: Participants will understand and be able to discuss important issues and specific tactical detail regarding drug diversion.
  • Accountability: Participants will understand who may be accountable for responding to, and prioritizing, the drill down tactical detail for prevention, preparedness, protection, and performance improvement in the area of drug diversion.
  • Ability: Participants will learn about specific tactical competencies important to combating drug diversion and opioid related problems in the workforce.
  • Action: Participants will learn what actions they may need to take in order to take a tactical approach to improvement of the risks of drug diversion in their institutions.

CE Participation Documentation

Texas Medical Institute of Technology, approved by the California Board of Registered Nursing, Provider Number 15996, will be issuing 1.5 contact hours for this webinar. TMIT is only providing nursing credit at this time.

To request a Participation Document, please click here.

……………………………………………………………………………………………………..

Session Speakers and Panelists

Kimberly S. New, JD, BSN, RN
Kimberly S. New, JD, BSN, RN Drug Diversion - A Drill Down Approach
Bio
William Adcox, MBA
William Adcox, MBADiscussion and Reaction to Presentation
Bio
Vicki King, MSCJ
Vicki King, MSCJDiscussion and Reaction to Presentation
Bio
C. R. Denham, II, MD
C. R. Denham, II, MDIn the News and Recent Polling
Bio
Arlene Salamendra
Arlene SalamendraDiscussion and Reaction to Presentation AND the Voice of Patient and Family
Bio

Related Resources

  1. DEA. Fentanyl: Preventing Occupational Exposure to Emergency Responders. DEA. Available at: https://www.cdc.gov/niosh/topics/fentanyl/risk.html.   
  2. Boyles S. Mass. Study: Illicit Fentanyl Involved in Most Opioid Fatalities. Stat: Reporting from the Frontiers of Health and Medicine. 2017 Apr 30. Available at: http://www.medpagetoday.com/psychiatry/addictions/64558?pop=0&ba=1&xid=tmd-%20md&hr=trendMD.   
  3. DEA: Officer Safety Alert. Carfentanil: A Dangerous New Factor in the U.S. Opioid Crisis. DEA. 2017 May 17.
    Available at: http://iaclea.org/visitors/PDFs/OfficerSafetyAlert-9.27.16.pdf.   
  4. Moshtaghian, A. Police officer overdoses after brushing fentanyl powder off his uniform. CNN. 2017 May 16.
    Available at: http://www.cnn.com/2017/05/16/health/police-fentanyl-overdose-trnd/.   
  5. CDC website (current Opioid Overdose statistics): https://www.cdc.gov/drugoverdose/index.html.   
  6. Editorial Board. Painkiller abuses and ignorance. The New York Times March 2, 2015:A18. Available at http://www.nytimes.com/2015/03/02/opinion/painkiller-abuses-and-ignorance.html.   
  7. Frenk SM, Porter KS, Paulozzi LJ. Prescription opioid analgesic use among adults: United States, 1999-2012. NCHS Data Brief. 2015 Feb;(189):1-8. Available at http://www.cdc.gov/nchs/data/databriefs/db189.pdf.   
  8. Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA 2015 Mar 3;313(9):891-2. Available at http://jama.jamanetwork.com/article.aspx?articleid=2107540.   
  9. Islam MM, McRae IS. An inevitable wave of prescription drug monitoring programs in the context of prescription opioids: pros, cons and tensions. BMC Pharmacol Toxicol 2014 Aug 16;15:46. Available at http://www.biomedcentral.com/content/pdf/2050-6511-15-46.pdf.   
  10. [No authors listed.] Safe use of opioids in hospitals. Sentinel Event Alert Issue 49. Oakbrook Terrace (IL): The Joint Commission; 2012 Aug 8. Available at http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.pdf.   
  11. Warner M, Hedegaard H, Chen L-H. Trends in drug-poisoning deaths involving opioid analgesics and heroin: United States, 1999-2012. NCHS Health E-Stat. Atlanta (GA): Centers for Disease Control and Prevention; 2014 Dec 2. Available athttp://www.cdc.gov/nchs/data/hestat/drug_poisoning/drug_poisoning_deaths_1999-2012.pdf.   
  12. Yokell MA, Delgado MK, Zaller ND, et al. Presentation of prescription and nonprescription opioid overdoses to US emergency departments. JAMA Intern Med 2014 Dec;174(12):2034-7. Available at http://archinte.jamanetwork.com/article.aspx?articleid=1918924.   
  13. IOM (Institute of Medicine). Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Report Brief. Washington, DC: The National Academies Press; 2011 Jun. Available athttp://www.iom.edu/~/media/Files/Report%20Files/2011/Relieving-Pain-in-America-A-Blueprint-for-Transforming-Prevention-Care-Education-Research/Pain%20Research%202011%20Report%20Brief.pdf.   
  14. IOM (Institute of Medicine). Committee on Advancing Pain Research, Care, and Education; Board on Health Sciences Policy. Relieving pain in America: a blueprint for transforming prevention, care, education, and research. Washington, DC: The National Academies Press; 2011 Jun. Available at http://www.nap.edu/catalog.php?record_id=13172.   
  15. U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. National Action Plan for Adverse Drug Event Prevention. Washington, DC: U.S. Department of Health and Human Services; 2014. Available at http://www.health.gov/hai/pdfs/ADE-Action-Plan-508c.pdf.   
  16. Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop. Ann Intern Med 2015 Feb 17;162(4):276-86. Available at http://annals.org/data/Journals/AIM/932765/0000605-201502170-00006.pdf.   
  17. National Quality Forum. Safe Practice 1: Culture of Safety Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  18. National Quality Forum. Safe Practice 2: Culture Measurement, Feedback, and Intervention. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  19. National Quality Forum. Safe Practice 3: Teamwork Training and Skill Building. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  20. National Quality Forum. Safe Practice 4: Risks and Hazards. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  21. National Quality Forum. Safe Practice 18: Pharmacist Leadership Structures and Systems. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.   
  22. National Quality Forum. Chapter 9: Opportunities for Patient and Family Involvement. IN: Safe Practices for Better Healthcare – 2010 Update: A Consensus Report. Washington, DC: National Quality Forum; 2010. Available at http://www.qualityforum.org/Publications/2010/04/Safe_Practices_for_Better_Healthcare_%E2%80%93_2010_Update.aspx.